Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05874466
SenseToKnow Autism Screening Device Validation Study
Sponsor: Duke University
View on ClinicalTrials.gov
Summary
This is a pivotal, prospective, double-blind, study to evaluate the sensitivity and specificity of the SenseToKnow device for the detection of autism spectrum disorder in children 16-36 months of age.
Official title: SenseToKnow STAR Study: A Study of Technologies for Assessing Children's Development
Key Details
Gender
All
Age Range
16 Months - 36 Months
Study Type
OBSERVATIONAL
Enrollment
350
Start Date
2023-07-07
Completion Date
2027-12
Last Updated
2026-03-06
Healthy Volunteers
Yes
Conditions
Locations (1)
Duke University
Durham, North Carolina, United States